Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EBOS Group is the largest human and animal healthcare company in Australia and New Zealand, specializing in the marketing, wholesale, and distribution of pharmaceutical and medical products. The company operates a diverse portfolio of businesses including Symbion, a major pharmaceutical wholesaler, and TerryWhite Chemmart, one of Australia's largest retail pharmacy networks. Beyond distribution, EBOS provides contract logistics, clinical trial support, and medical technology solutions through its LifeHealthcare division. The group also maintains a significant Animal Care segment, owning premium brands such as Black Hawk and Vitapet. With over 5,000 employees across more than 100 locations, EBOS serves as a critical infrastructure provider for the Australasian healthcare sector. The company is dual-listed on the Australian and New Zealand stock exchanges and continues to expand its footprint into Southeast Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ebos Group.